Related Experiment Video
Updated: May 15, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Tiotropium for adults with inadequately controlled persistent asthma.
1Virginia Commonwealth University Health System, Richmond, VA, USA.
The Annals of Pharmacotherapy
|January 18, 2013
Summary
Tiotropium shows promise in improving lung function and reducing steroid needs for adults with persistent asthma. Further research is needed to confirm its long-term benefits and impact on quality of life.
Area of Science:
- Pulmonology
- Pharmacology
- Clinical Medicine
Background:
- Persistent asthma often remains inadequately controlled despite inhaled corticosteroid (ICS) use.
- Long-term, high-dose ICS therapy raises concerns regarding serious adverse effects.
- Tiotropium is emerging as a potential adjunctive therapy for difficult-to-manage asthma.
Purpose of the Study:
- To evaluate the efficacy of tiotropium in adults with persistent asthma.
- To assess the steroid-sparing potential of tiotropium in this patient population.
- To review current literature on tiotropium's role in asthma management.
Main Methods:
- A literature search was conducted using MEDLINE/PubMed (1966-October 2012) with terms 'asthma' and 'tiotropium'.
- Reference citations of relevant articles were also reviewed.
- English-language case reports and 5 clinical trials meeting inclusion criteria were analyzed.
Main Results:
- Tiotropium demonstrated improvements in pulmonary function markers.
- The use of tiotropium led to reduced corticosteroid requirements.
- A significant trial showed increased time to first asthma exacerbation with tiotropium use.
Conclusions:
- Tiotropium appears promising for persistent asthma, potentially improving lung function and reducing steroid dependence.
- Further robust clinical trials are necessary to confirm benefits on quality of life and exacerbation rates.
- Long-term efficacy, safety, optimal patient selection, and delivery methods require additional investigation.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...